Sun Pharmaceutical Industries Ltd. closed 13.98% short of its 52-week high of 1,960.20 rupees, which the company achieved on September 30th.

Sun Pharmaceutical Industries Ltd. closed 10.99% short of its 52-week high of 1,960.20 rupees, which the company achieved on ...

New Delhi: Sun Pharmaceutical Industries (Sun Pharma) has launched its corporate brand campaign, aiming to highlight its impact on the lives of people. Created by Ogilvy Mumbai, the campaign is ...

All these firms recorded higher growth rates compared to Indian Pharma Market. Among other outperformers were Sun Pharmaceutical Industries and Glenmark Pharmaceuticals. Sun Pharmaceuticals marked ...

Drug makers Glenmark, Sun Pharma and Zydus are recalling products in the US for manufacturing issues, the US Food and Drug Administration (USFDA) said in its latest Enforcement Report. As per the ...

Garfunkel, one half of Rock and Roll Hall of Fame duo Simon & Garfunkel, is speaking out for the first time about living with psoriasis in Sun Pharma’s I LUV YA for The Long Haul campaign, which aims ...

Drug makers Glenmark, Sun Pharma and Zydus are recalling products in the US for manufacturing issues, the US Food and Drug Administration (USFDA) said in its latest Enforcement Report. As per the US ...

As of 11:00:40 AM GMT+5:30. Market Open. On Sunday, India-based Sun Pharmaceutical Industries Limited agreed to acquire U.S.-based immunotherapy and targeted oncology company Checkpoint ...

Benchmark indices, which opened slightly in the green, turned negative as pharma giants like Sun Pharma, Cipla, Lupin, and Aurobindo Pharma tumbled in early trade. Trump’s order seeks to fast ...

the stock of the country’s largest pharmaceutical (pharma) company, Sun Pharmaceutical Industries, has clawed back nearly half of those losses. Photograph: Francis Mascarenhas/Reuters Recent ...

Sun Pharma successfully removed an injunction in the US on the launch of its Leqselvi for alopecia areata, a common form of hair loss, that was sought by rival Incyte. The decision in the US Court ...